Related Experiment Video
Updated: Aug 16, 2025

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Systemic Lidocaine Infusions for Pediatric Patients with Cancer-Related Pain
Emily Rav1, Rachna Sheth2, Ali H Ahmad3
1Pediatric Oncology Fellowship Program, Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Insights
Systemic lidocaine infusions offer a safe and effective option for managing refractory cancer pain in pediatric patients. This approach can decrease pain scores and improve the quality of life for children undergoing cancer treatment.
Area of Science:
- Pediatric Oncology
- Pain Management
- Pharmacology
Background:
- Pediatric cancer patients experience significant distress from cancer-related pain and treatment.
- Refractory pain presents a therapeutic challenge in this population.
- Analgesic regimen selection requires careful consideration of individual patient factors.
Purpose of the Study:
- To review the use of systemic lidocaine infusions for analgesia in pediatric oncology patients.
- To evaluate the safety and efficacy of lidocaine for refractory cancer pain.
Main Methods:
- Literature review of studies on systemic lidocaine infusions in pediatric oncology.
- Analysis of patient-reported outcomes, including pain scores and quality of life.
Main Results:
- Systemic lidocaine infusions have demonstrated safety and efficacy in prior studies.
- Patients reported decreased pain scores following lidocaine treatment.
- Improved quality of life was observed in patients receiving lidocaine.
Conclusions:
- Systemic lidocaine infusions show potential as an analgesic option for refractory pain in pediatric cancer.
- Lidocaine's favorable side effect profile supports its consideration in this patient group.
Abstract:
Pediatric patients with cancer experience significant distress from both treatment and cancer-related pain. Careful selection of an analgesic regimen should be based upon individual patient factors, including the level of pain, response to therapy, and physiologic profile. Refractory pain is a therapeutic dilemma frequently encountered in the pediatric cancer setting. Systemic lidocaine infusions have been described as both safe and efficacious, as prior studies show patients reporting decreased pain scores and improved quality of life after lidocaine treatment. Given the favorable side effect profile of lidocaine, it has the potential to be considered for analgesia in the setting of refractory pain. This review discusses the use of systemic lidocaine infusions for analgesia in pediatric oncology patients with cancer-related pain.
More Related Videos
Related Concept Videos
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Local Anesthetics: Clinical Application as Spinal Anesthesia
Local Anesthetics: Common Agents and Their Applications
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia
Parenteral Anesthetics: Overview

